Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis

European Respiratory Journal

Volumn 21, Issue 3, 2003, Pages 421-428

  Fehrenbach, Heinz ^a   Zissel, G ^b   Goldman, T ^c   Tschernig, T ^d   Vollmer, E ^c   Pabst, R ^d   Muller Quernheim J ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c RESEARCH CENTER BORSTEL   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Alveolar macrophages; Granuloma formation; Sarcoidosis; Tumour necrosis factor

Indexed keywords

CD3 ANTIGEN; CD68 ANTIGEN; CYTOKERATIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL AGGREGATION; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ALVEOLUS MACROPHAGE; LUNG GRANULOMA; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESPIRATORY TRACT PARAMETERS; SARCOIDOSIS; T LYMPHOCYTE; TISSUE SECTION; TRANSBRONCHIAL BIOPSY;

EID: 0037341640     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00083002     Document Type: Article

References (34)

1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224-1234.
2. Müller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12: 716-738.
3. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999; 14: 735-737.
4. Pabst R, Schuster M, Tschernig T. Lymphocyte dynamics in the pulmonary microenvironment: implications for the pathophysiology of pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 197-202.
5. Conron M, Du Bois RM. Immunological mechanisms in sarcoidosis. Clin Exp Allergy 2001; 31: 543-554.
6. Kunkel SL, Chensue SW, Strieter RM, Lynch JP, Remick DG. Cellular and molecular aspects of granulomatous inflammation. Am J Respir Cell Mol Biol 1989; 1: 439 -447.
7. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10: 411-452.
8. Müller-Quernheim J, Pfeifer S, Mannel D, Strausz J, Ferlinz R. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992; 145: 187-192.
9. Hunninghake GW. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Am Rev Respir Dis 1984; 129: 569-572.
10. Müller-Quernheim J, Saftini C, Sondermeyer P, Crystal RG. Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis. J Immunol 1986; 137: 3475-3483.
11. Prasse A, Georges CG, Biller H, et al. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol 2000; 122: 241-248.
12. Mollers M, Aries SP, Dromann D, Mascher B, Braun J, Dalhoff K. Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax 2001; 56: 487-493.
13. Wahlström J, Katchar K, Wigzell H, Olerup O, Eklund A, Grunewald J. Analysis of intracellular cytokines in CD4(+) and CD8(+) lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med 2001; 163: 115-121.
14. Zissel G, Ernst M, Rabe K, et al. Human alveolar epithelial cells type II are capable of regulating T-cell activity. J Investig Med 2000; 48: 66-75.
15. Nash JR, McLaughlin PJ, Butcher D, Corrin B. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis. Histopathology 1993; 22: 343-347.
16. Piguet PF, Ribaux C, Karpuz V, Grau GE, Kapanci Y. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol 1993; 143: 651-655.
17. McRitchie DI, Isowa N, Edelson JD, et al. Production of tumour necrosis factor alpha by primary cultured rat alveolar epithelial cells. Cytokine 2000; 12: 644-654.
18. Armstrong L, Foley NM, Millar AB. Inter-relationship between tumour necrosis factor-alpha (TNF-α) and TNF soluble receptors in pulmonary sarcoidosis. Thorax 1999; 54: 524-530.
19. Ziegenhagen MW, Benner UK, Zissel G, et al. Sarcoidosis TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med 1997; 156: 1586-1592.
20. Fehrenbach H, Kasper M, Tschernig T, et al. Keratinocyte growth factor-induced hyperplasia of rat alveolar type II cells in vivo is resolved by differentiation into type I cells and by apoptosis. Eur Respir J 1999; 14: 534-544.
21. Kasper M, Roehlecke C, Witt M, et al. Induction of apoptosis by glyoxal in human embryonic lung epithelial cell line L132. Am J Respir Cell Mol Biol 2000; 23: 485-491.
22. ATS, ERS, WASOG. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
23. Baughman RP, Strohofer SA, Buchsbaum J, Lower EE. Release of tumor necrosis factor by alveolar macrophages of 'patients with sarcoidosis. J Lab Clin Med 1990; 115: 36-42.
24. Pantelidis P, McGrath DS, Southcott AM, du Bois RM. Single-cell analysis: a novel approach to tumour necrosis factor-alpha synthesis and secretion in sarcoidosis. Eur Respir J 2002; 20: 1179-1184.
25. Myatt N, Coghill G, Morrison K, Jones D, Cree IA. Detection of tumour necrosis factor alpha in sarcoidosis and tuberculosis granulomas using in situ hybridisation. J Clin Pathol 1994; 47: 423-426.
26. Ziegenhagen MW, Schrum S, Zissel G, Zipfel PF, Schlaak M, Müller-Quernheim J. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Investig Med 1998; 46: 223-231.
27. Capelli A, Di Stefano A, Lusuardi M, Gnemmi I, Donner CF. Increased macrophage inflammatory protein-1alpha and macrophage inflammatory protein-1beta levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis. Am J Respir Crit Care Med 2002; 165: 236-241.
28. Agostini C, Facco M, Chilosi M, Semenzato G. Alveolar macrophage-T cell interactions during Th1-type sarcoid inflammation. Microsc Res Tech 2001; 53: 278-287.
29. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983; 308: 793-800.
30. Robinson BW, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar-macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985; 75: 1488-1495.
31. Hoshino T, Itoh K, Gouhara R, et al. Spontaneous production of various cytokines except IL-4 from CD4+ T cells in the affected organs of sarcoidosis patients. Clin Exp Immunol 1995; 102: 399-405.
32. Bäumer I, Zissel G, Schlaak M, Müller-Quernheim J. Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1997; 16: 171-177.
33. Warshamana GS, Corti M, Brody AR. TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolaralveolar epithelial and mesenchymal cells: TNF-alpha induces TGF-beta(1). Exp Mol Pathol 2001; 71: 13-33.
34. Nash JR, McLaughlin PJ, Hoyle C, Roberts D. Immunolocalization of tumour necrosis factor alpha in lung tissue from patients dying with adult respiratory distress syndrome. Histopathology 1991; 19: 395-402.